22 citations
,
September 2017 in “Skin appendage disorders” This report describes a case where treatment with the JAK inhibitor ruxolitinib significantly improved beard growth in a patient with severe alopecia areata, emphasizing its potential benefits for populations where beard hair holds cultural significance.
November 2025 in “SKIN The Journal of Cutaneous Medicine” This study aims to assess the real-world effectiveness of baricitinib, a JAK inhibitor, for promoting regrowth of nasal, genital, and beard hair in patients with severe alopecia areata, expanding on findings from the BRAVE-AA clinical trial. Results are not reported.
3 citations
,
April 2020 in “Facial Plastic Surgery Clinics of North America” This review discusses the increasing demand for facial hair transplantation in hair restoration, noting its benefits and the natural-appearing results achieved through modern techniques, but it reports no new clinical results.
January 2025 in “Journal of Cutaneous Medicine and Surgery” In this clinical trial, adding topical calcipotriol to intralesional triamcinolone acetonide significantly increased hair regrowth efficacy in scalp alopecia areata patches compared to steroids alone, but not in beard patches, with a lower incidence of atrophy observed.
March 2024 in “Molecules/Molecules online/Molecules annual” This study optimized the extraction process of bear grease through enzymatic hydrolysis and found that it was rich in unsaturated fatty acids, enhancing its hair growth-promoting properties in mice compared to traditional methods.
